文献速递脑血管病

灌注成像与急性缺血性卒中大核心患者的临床结局

Perfusion Imaging and Clinical Outcome in Acute Ischemic Stroke with Large Core.
PubMed 文献 · Ann Neurol · 2021-07-29

本研究比较了发病6小时内大核心(>50 ml)前循环大血管闭塞患者接受机械取栓联合最佳药物治疗与单纯最佳药物治疗的结局。结果显示灌注成像的错配比(MMRatio)显著修饰取栓疗效,MMRatio>1.2者取栓与良好结局相关(调整OR 6.8),而≤1.2者无获益。

要点

  • 大核心卒中患者中,MMRatio>1.2者机械取栓与90天良好结局独立相关。
  • MMRatio≤1.2的大核心患者未能从机械取栓中获益。
  • 取栓组随访影像的实质出血更常见,且不受MMRatio影响。

核心结论

  • 灌注成像可能有助于筛选哪些大核心患者应考虑机械取栓。
  • MMRatio>1.2的大核心患者取栓与更高良好结局率相关,而MMRatio≤1.2者无此关联。
  • 需要随机对照研究进一步验证。

研究设计与样本

  • 比较两个队列:前瞻性研究中接受机械取栓+最佳药物治疗的大核心患者,与取栓前时代前瞻性登记中仅接受最佳药物治疗的大核心患者。
  • 共纳入107例发病6小时内的大核心(DWI或CT灌注RAPID定义>50 ml)大血管闭塞患者,其中56例取栓+药物治疗,51例单纯药物治疗。
  • 主要结局为90天改良Rankin量表≤2分。

主要发现

  • 平均年龄68±15岁,核心体积中位数99 ml(IQR 72-131),MMRatio中位数1.4(IQR 1.0-1.9)。
  • MMRatio对取栓疗效有显著交互作用(连续MMRatio p交互<0.001)。
  • MMRatio>1.2者取栓与良好结局相关(调整OR 6.8,95%CI 1.7-27.0),MMRatio≤1.2者无关联(调整OR 0.7,95%CI 0.1-6.2)。
  • 核心≥70 ml亚组中MMRatio≥1.8有类似发现。
  • 取栓+药物治疗组随访影像实质出血更频繁,与MMRatio无关。

关键数值与推荐

  • 大核心定义:DWI或CT灌注(RAPID)上>50 ml。
  • MMRatio=临界低灌注体积/核心体积。
  • MMRatio>1.2作为取栓获益的筛选阈值(调整OR 6.8,95%CI 1.7-27.0)。
  • 核心≥70 ml亚组中MMRatio≥1.8提示获益。

临床怎么用

  • 对发病6小时内大核心大血管闭塞患者,可借助灌注成像计算MMRatio辅助筛选机械取栓候选者。
  • MMRatio>1.2的大核心患者可能从机械取栓联合最佳药物治疗中获益。
  • MMRatio≤1.2的大核心患者取栓未显示获益,决策需个体化。
  • 取栓后需警惕实质出血风险增加。

局限性

  • 非随机对照设计,取栓组来自前瞻性研究,对照组来自取栓前时代登记,存在时代偏倚。
  • 样本量较小(共107例),结果需随机研究验证。
  • 对照组静脉溶栓率更高,可能影响组间比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Mechanical thrombectomy (MT) is not recommended for acute stroke with large vessel occlusion (LVO) and a large volume of irreversibly injured tissue ("core"). Perfusion imaging may identify a subset of patients with large core who benefit from MT. METHODS: We compared two cohorts of LVO-related patients with large core (>50 ml on diffusion-weighted-imaging or CT-perfusion using RAPID), available perfusion imaging, and treated within 6 hours from onset by either MT + Best Medical Management (BMM) in one prospective study, or BMM alone in the pre-MT era from a prospective registry. Primary outcome was 90-day modified Rankin Scale ≤2. We searched for an interaction between treatment group and amount of penumbra as estimated by the mismatch ratio (MMRatio = critical hypoperfusion/core volume). RESULTS: Overall, 107 patients were included (56 MT + BMM and 51 BMM): Mean age was 68 ± 15 years, median core volume 99 ml (IQR: 72-131) and MMRatio 1.4 (IQR: 1.0-1.9). Baseline clinical and radiological variables were similar between the two groups, except for a higher intravenous thrombolysis rate in the BMM group. The MMRatio strongly modified the clinical outcome following MT (pinteraction < 0.001 for continuous MMRatio); MT was associated with a higher rate of good outcome in patients with, but not in those without, MMRatio>1.2 (adjusted OR [95% CI] = 6.8 [1.7-27.0] vs 0.7 [0.1-6.2], respectively). Similar findings were present for MMRatio ≥1.8 in the subgroup with core ≥70 ml. Parenchymal hemorrhage on follow-up imaging was more frequent in the MT + BMM group regardless of the MMRatio. INTERPRETATION: Perfusion imaging may help select which patients with large core should be considered for MT. Randomized studies are warranted. ANN NEUROL 2021;90:417-427.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Seners P, Oppenheim C, Turc G, et al. Perfusion Imaging and Clinical Outcome in Acute Ischemic Stroke with Large Core. Ann Neurol. 2021. PMID: 34216396. doi:10.1002/ana.26152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。